Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials

Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials

Purpose: Treatment of chemotherapy-induced peripheral neuropathy (CIPN) is challenging for clinicians, and many clinical trials and meta-analyses on CIPN are controversial. There are also few comparisons of the efficacy among drugs used to treat CIPN. Therefore, this systematic review aimed to study...

Full description

Bibliographic Details
Main Authors:	Chenkun Wang, Si Chen, Weiwei Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Pharmacology
Subjects:	chemotherapy-induced peripheral neuropathy (CIPN) rrandomised controlled trial drugs treatment efficacy safety
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1080888/full

Similar Items

Exercise for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
by: Yingjie Huang, et al.
Published: (2024-01-01)

Corrigendum: Exercise for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials
by: Yingjie Huang, et al.
Published: (2024-03-01)

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis
by: Megan Crichton, et al.
Published: (2022-06-01)

Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)

Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice
by: Aryah Basu, et al.
Published: (2024-01-01)

Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
by: Rozalyn L. Rodwin, et al.
Published: (2022-03-01)

Skin Extracellular Matrix Breakdown Following Paclitaxel Therapy in Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Nathan P. Staff, et al.
Published: (2023-08-01)

Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms
by: L. Brett Whalen, et al.
Published: (2022-02-01)

Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center
by: Florent Bienfait, et al.
Published: (2023-01-01)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
by: Ines Klein, et al.
Published: (2021-09-01)

Longitudinal RNA Sequencing of Skin and DRG Neurons in Mice with Paclitaxel-Induced Peripheral Neuropathy
by: Anthony M. Cirrincione, et al.
Published: (2022-05-01)

Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelone: Study protocol for a randomized controlled trial
by: Chao Lu, et al.
Published: (2023-02-01)

A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy
by: Yusuke Fukuda, et al.
Published: (2017-08-01)

Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
by: Zia Khan, et al.
Published: (2023-06-01)

Randomized clinical trial quantifying the effectiveness of a self-monitoring intervention in cancer patients with peripheral neuropathy: A quantitative study
by: Kiyoko Kanda, et al.
Published: (2023-04-01)

Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy
by: Fumiko Sekiguchi, et al.
Published: (2020-12-01)

Mechanisms of Chemotherapy-Induced Neurotoxicity
by: Halina Was, et al.
Published: (2022-03-01)

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
by: Nicolette Tay, et al.
Published: (2022-10-01)

Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy (CIPN) with Non-Pharmacological Interventions: Clinical Recommendations from a Systematic Scoping Review and an Expert Consensus Process
by: Nadja Klafke, et al.
Published: (2023-01-01)

Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
by: Sandy Eldridge, et al.
Published: (2021-11-01)

The Therapeutic Potential of Monocyte/Macrophage Manipulation in the Treatment of Chemotherapy-Induced Painful Neuropathy
by: Karli Montague, et al.
Published: (2017-11-01)

A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
by: Cindy Tofthagen, et al.
Published: (2022-01-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Efficacy of electroacupuncture with different frequencies in the treatment of chemotherapy-induced peripheral neuropathy: A study protocol for a randomized controlled trial
by: Chao Lu, et al.
Published: (2022-07-01)

Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy
by: Corine de Jong, et al.
Published: (2023-01-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01)

Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

The Role of Interleukin-20 in Paclitaxel-Associated Peripheral Neuropathy in Non-Metastatic Breast Cancer Patients Receiving Chemotherapy
by: Kubilay Karaboyun, et al.
Published: (2023-11-01)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
by: Pasquale Sansone, et al.
Published: (2022-08-01)

A review of movement disorders in chemotherapy-induced neurotoxicity
by: Allison B. Wang, et al.
Published: (2021-01-01)

Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy
by: Yang Hu, et al.
Published: (2024-02-01)

Extremity Exercise Program in Breast Cancer Survivors Suffering from Chemotherapy-Induced Peripheral Neuropathy: A Feasibility Pilot Study
by: Chih-Jung Wu, et al.
Published: (2022-04-01)

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial
by: Bernardino Clavo, et al.
Published: (2021-03-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

A Limb Hypothermia Wearable for Chemotherapy-Induced Peripheral Neuropathy: A Mixed-Methods Approach in Medical Product Development
by: Jonathan Binder, et al.
Published: (2020-12-01)

Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants
by: Maho Tsubota, et al.
Published: (2019-10-01)

Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review
by: Xiaoli Lv, et al.
Published: (2023-03-01)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
by: Sonoko Misawa, et al.
Published: (2023-11-01)